on 22 Mar 2022
Last Applicant/ Owned by
3554 NE 85th St. Suite A
Seattle
WA
98115
Serial Number
90285295 filed on 28th Oct 2020
Registration Number
6675095 registered on 22nd Mar 2022
Correspondent Address
Maha Jafarey
Filing Basis
1. use application currently
Disclaimer
NO DATA
Investor development and management in the nature of business intermediary services relating to the matching of potential private investors with entrepreneurs needing funding; Advisory board development and management being personnel management services; Regulatory compliance development and management in the nature of regulatory submission management, namely, assisting others in preparing and fil Read More
Investor development and management in the nature of business intermediary services relating to the matching of potential private investors with entrepreneurs needing funding; Advisory board development and management being personnel management services; Regulatory compliance development and management in the nature of regulatory submission management, namely, assisting others in preparing and filing applications for new drugs with governmental regulatory bodies
01st Mar 2020
01st Mar 2020
Research and development in the pharmaceutical and biotechnology fields, Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research and development of vaccines and medicines; Research and development services in the field of antibodies; Biochemical research and development; Conducting clinical trials for others; Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Medical and scientific research in the field of cancer treatment and diagnosis; Medical and scientific research, namely, conducting clinical trials for others; Medical research services in the field of cancer; Pharmaceutical research and development; Providing a web site featuring technology enabling physicians to access resources in clinical medicine; Providing a website featuring educational information in the field of clinical research; Providing laboratory research services in the field of gene expression, namely, cancer biology; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical testing services and information in the field of cancer research and disease classification; Scientific research and development; Scientific and technological services, namely, research and design in the field of integrated system architecture that allows for the rapid development of highly interactive and customizable learning applications; Scientific research for medical purposes in the area of cancerous diseases; Scientific research for medical purposes in the field of cancer and acute and chronic devastating diseases and conditions beyond cancer; Stem cell research services; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy
01st Mar 2020
01st Mar 2020
No 90285295
No Service Mark
No
No
No
No
No
No
No
No
No
01.09.05 -
Atoms or molecular models
26.01.03 -
Incomplete circles (more than semi-circles)
26.01.21 -
Circles that are totally or partially shaded
27.03.05 -
Representations of objects forming letters or numerals, including punctuation
Status Date | Action Taken |
---|---|
22nd Mar 2022 | REGISTERED-PRINCIPAL REGISTER |
04th Jan 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
04th Jan 2022 | PUBLISHED FOR OPPOSITION |
15th Dec 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
01st Dec 2021 | APPROVED FOR PUB - PRINCIPAL REGISTER |
01st Dec 2021 | EXAMINER'S AMENDMENT ENTERED |
01st Dec 2021 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
01st Dec 2021 | EXAMINERS AMENDMENT E-MAILED |
01st Dec 2021 | EXAMINERS AMENDMENT -WRITTEN |
01st Jul 2021 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |